Excelsior Advisor Network LLC
Position in IOVA — Iovance Biotherapeutics, Inc.
CIK 2110679
SCOTTSDALE, AZ
Position in IOVA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,421,123
+$7,371,457 QoQ
Shares Held
1,783,924
+12507.2% QoQ
Ownership
0.394%
of shares outstanding
% of Portfolio
1.35%
of 13F equity value
Holder Rank
#30
of 289 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 3%
Shared 0%
None 97%
Common Shares in IOVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Excelsior Advisor Network LLC holds $11,267,078 across 10 Biotechnology names. IOVA ranks #1 (65.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IOVA |
Iovance Biotherapeutics, Inc.
This page
|
1,783,924 | $7,421,123 | |
| 2 | TGTX |
Tg Therapeutics, Inc.
|
30,385 | $1,669,351 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,060 | $526,533 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
626 | $390,336 | |
| 5 | INCY |
Incyte Corp
|
2,976 | $337,359 | |
| 6 | SMMT |
Summit Therapeutics Inc.
|
17,975 | $261,895 | |
| 7 | VKTX |
Viking Therapeutics, Inc.
|
6,327 | $246,816 | |
| 8 | ALLO |
Allogene Therapeutics, Inc.
|
95,991 | $199,661 |
All Filings in IOVA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,421,123 | 1,783,924 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $49,666 | 14,150 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $41,359 | 15,150 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||